A. Jaouen, S. Vessieres, and . Top, Ferrocifen type anti cancer drugs, Chemical Society Reviews, vol.54, issue.24, pp.8802-8817, 2015.
DOI : 10.1002/anie.201503048
URL : https://hal.archives-ouvertes.fr/hal-01221048

S. Jaouen, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines

L. Laine, E. Adriaenssens, A. Vessières, G. Jaouen, C. Corbet et al., The in??vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer, Biomaterials, vol.34, issue.28, pp.6949-6956, 2013.
DOI : 10.1016/j.biomaterials.2013.05.065
URL : https://hal.archives-ouvertes.fr/hal-01230382

G. Michard, A. Jaouen, B. A. Vessières, and . Bernard, Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines, Journal of Inorganic Biochemistry, vol.102, issue.11, 1980.
DOI : 10.1016/j.jinorgbio.2008.07.014

C. Vessières, J. M. Corbet, N. Heldt, N. Lories, I. Jouy et al., A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines, Journal of Inorganic Biochemistry, vol.104, issue.5, pp.503-511, 2010.
DOI : 10.1016/j.jinorgbio.2009.12.020

A. Hillard, A. Vessières, L. Thouin, G. Jaouen, and C. Amatore, Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast cancer drug candidates, Angew. Chem., Int. Ed, pp.45-285, 2006.

A. Citta, A. Folda, P. Bindoli, S. Pascal-pigeon, A. Top et al., Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells, Journal of Medicinal Chemistry, vol.57, issue.21, pp.8849-8859, 2014.
DOI : 10.1021/jm5013165
URL : https://hal.archives-ouvertes.fr/hal-01230376

Y. P. Hu, J. C. Liu, J. G. Wu, and . Fang, Small molecule inhibitors of mammalian thioredoxin reductase, Free Radical Biol. Med, vol.52, pp.257-265, 2012.

A. P. Gandin and . Fernandes, Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents, Molecules, vol.62, issue.7, pp.12732-12756, 2015.
DOI : 10.1200/JCO.2005.10.217

Y. J. Liu, S. H. Li, G. S. Yu, and . Zhao, Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents, Current Drug Targets, vol.13, issue.11, pp.1432-1444, 2012.
DOI : 10.2174/138945012803530224

. Bellelli, Thioredoxin Reductase and its Inhibitors, Curr. Protein Pept. Sci, vol.15, pp.621-646, 2014.

M. P. Bindoli and . Rigobello, Principles in Redox Signaling: From Chemistry to Functional Significance, Antioxidants & Redox Signaling, vol.18, issue.13, pp.1557-1593, 2013.
DOI : 10.1089/ars.2012.4655

M. P. Bindoli, G. Rigobello, C. Scutari, A. Gabbiani, L. Casini et al., Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs, Coordination Chemistry Reviews, vol.253, issue.11-12, pp.1692-1707, 2009.
DOI : 10.1016/j.ccr.2009.02.026

Z. S. Lee, O. Buriez, F. Chau, E. Labbé, R. Ganguly et al., Synthesis, Characterization, and Biological Properties of Osmium-Based Tamoxifen Derivatives - Comparison with Their Homologues in the Iron and Ruthenium Series, European Journal of Inorganic Chemistry, vol.76, issue.25, pp.4217-4225, 2015.
DOI : 10.1021/ac040087x
URL : https://hal.archives-ouvertes.fr/hal-01624354

A. Luthman and . Holmgren, Rat liver thioredoxin and thioredoxin reductase: purification and characterization, Biochemistry, vol.21, issue.26, pp.6628-6633, 1982.
DOI : 10.1021/bi00269a003

H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem, vol.193, pp.265-275, 1951.

G. Fang, J. Lu, and A. Holmgren, Thioredoxin Reductase Is Irreversibly Modified by Curcumin, Journal of Biological Chemistry, vol.11, issue.26, pp.25284-25290, 2005.
DOI : 10.1016/j.drup.2004.01.004
URL : http://www.jbc.org/content/280/26/25284.full.pdf

M. Prast-nielsen, I. Cebula, E. S. Pader, and . Arner, Noble metal targeting of thioredoxin reductase ??? covalent complexes with thioredoxin and thioredoxin-related protein of 14kDa triggered by cisplatin, Free Radical Biology and Medicine, vol.49, issue.11, pp.1765-1778, 2010.
DOI : 10.1016/j.freeradbiomed.2010.09.008

A. Clayton and G. S. Shadel, Isolation of mitochondria from cells and tissues, Cold Spring Harbor Protoc, 2014.

A. Bersani, J. R. Merwin, N. I. Lopez, G. D. Pearson, and G. F. Merrill, Protein Electrophoretic Mobility Shift Assay to Monitor Redox State of Thioredoxin in Cells, Methods Enzymol, vol.347, pp.317-326, 2002.
DOI : 10.1016/S0076-6879(02)47031-0

J. Ungerstedt, Y. Du, H. Zhang, D. Nair, and A. Holmgren, In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA), Free Radical Biology and Medicine, vol.53, issue.11, 2002.
DOI : 10.1016/j.freeradbiomed.2012.09.019

S. Pigeon, A. Top, M. Vessières, E. A. Huché, E. Hillard et al., Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior, Journal of Medicinal Chemistry, vol.48, issue.8, pp.2814-2821, 2005.
DOI : 10.1021/jm049268h
URL : https://hal.archives-ouvertes.fr/hal-00093015

I. Top, M. N. Efremenko, A. Rager, P. Vessieres, G. Yaswen et al., -Cp*Rh-Hydroxytamoxifen Complexes at the Estrogen, ER?? and ER?? Receptors, and Growth Inhibition to Breast Cancer Cells, )-O, and eta(6) Bonding Modes, pp.271-284, 2011.
DOI : 10.1021/ic1019372

Y. M. Jaouen, D. Frapart, C. Mansuy, and . Amatore, Deciphering the activation sequence of ferrociphenol anticancer drug candidates, Chem. ? Eur. J, vol.18, pp.6581-6587, 2012.

W. Fan, F. Zhang, and J. L. Bolton, 4-Hydroxylated Metabolites of the Antiestrogens Tamoxifen and Toremifene Are Metabolized to Unusually Stable Quinone Methides, Chemical Research in Toxicology, vol.13, issue.1, pp.45-52, 2000.
DOI : 10.1021/tx990144v

M. Davies, M. E. Malone, E. A. Martin, R. M. Jones, R. Jukes et al., Peroxidase Activation of 4-Hydroxytamoxifen to Free Radicals Detected by EPR Spectroscopy, Free Radical Biology and Medicine, vol.22, issue.3, pp.423-431, 1997.
DOI : 10.1016/S0891-5849(96)00345-0

I. Rybinskaya, A. Z. Kreindlin, and S. S. Fadeeva, On the problem of stabilization of ??-carbocationic centers in metallocene series. Related interconversions of permethylated ??-metallocenylcarbocations and metallocenium cation-radicals of the iron sub-group, Journal of Organometallic Chemistry, vol.358, issue.1-3, pp.363-374, 1988.
DOI : 10.1016/0022-328X(88)87090-6

I. Rybinskaya, A. Z. Kreindlin, Y. T. Struchkov, and A. I. Yanovsky, On the problem of the stabilization of ??-metallocenylcarbocation. Synthesis, properties and crystal structure of [C5Me5OH2+]BPh4?????CH2Cl2, Journal of Organometallic Chemistry, vol.359, issue.2, pp.233-243, 1989.
DOI : 10.1016/0022-328X(89)85433-6

R. Kim, H. W. Yoon, K. S. Kwon, S. R. Lee, and S. G. Rhee, Identification of Proteins Containing Cysteine Residues That Are Sensitive to Oxidation by Hydrogen Peroxide at Neutral pH, Analytical Biochemistry, vol.283, issue.2, pp.214-221, 2000.
DOI : 10.1006/abio.2000.4623

T. Du, H. H. Zhang, X. Zhang, J. Lu, and A. Holmgren, Thioredoxin 1 Is Inactivated Due to Oxidation Induced by Peroxiredoxin under Oxidative Stress and Reactivated by the Glutaredoxin System, Journal of Biological Chemistry, vol.1780, issue.45, pp.32241-32247, 2013.
DOI : 10.1016/S0076-6879(10)74005-2

C. Frantz and P. Wipf, Mitochondria as a target in treatment, Environmental and Molecular Mutagenesis, vol.83, pp.462-475, 2010.
DOI : 10.1016/j.bbadis.2005.10.007
URL : http://europepmc.org/articles/pmc2920596?pdf=render

R. Oehninger, I. Rubbiani, and . Ott, N-Heterocyclic carbene metal complexes in medicinal chemistry, Dalton Trans., vol.38, issue.10, pp.3269-3284, 2013.
DOI : 10.3109/03639045.2011.589853

H. Van-rijt, I. Romero-canelon, Y. Fu, S. D. Shnyder, and P. J. Sadler, Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells, Metallomics, vol.18, issue.suppl 5, pp.1014-1022, 2014.
DOI : 10.1016/j.copbio.2007.09.006

V. Imstepf, R. Pierroz, M. Rubbiani, T. Felber, G. Fox et al., Organometallic Rhenium Complexes Divert Doxorubicin to the Mitochondria, Organometallic Rhenium Complexes Divert Doxorubicin to the Mitochondria, pp.2792-2795, 2016.
DOI : 10.1021/cb500528c

P. Rigobello, Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights, Metallomics, vol.5, pp.1006-1015, 2013.

S. J. Rackham, P. J. Nichols, S. J. Leedman, A. Berners-price, and . Filipovska, A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: Implications for anticancer therapeutics targeted to mitochondria, Biochemical Pharmacology, vol.74, issue.7, pp.992-1002, 2007.
DOI : 10.1016/j.bcp.2007.07.022

. Mohr, Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents, J. Med. Chem, vol.55, pp.5518-5528, 2012.

. Filipovska, Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors, Free Radical Biol. Med, vol.50, pp.689-699, 2011.

P. Halestrap and A. P. Richardson, The mitochondrial permeability transition: A current perspective on its identity and role in ischaemia/reperfusion injury, Journal of Molecular and Cellular Cardiology, vol.78, pp.78-129, 2015.
DOI : 10.1016/j.yjmcc.2014.08.018

Z. S. Lee, O. Buriez, E. Labbé, S. Top, P. Pigeon et al., Oxidative Sequence of a Ruthenocene-Based Anticancer Drug Candidate in a Basic Environment, Organometallics, vol.33, issue.18, pp.4940-4946, 2014.
DOI : 10.1021/om500225k
URL : https://hal.archives-ouvertes.fr/hal-01230374

. Kovacic, Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: Clinical implications, Medical Hypotheses, vol.69, issue.3, pp.510-516, 2007.
DOI : 10.1016/j.mehy.2006.08.046